The Chemours Company (NYSE:CC) is at least 123.27% than its current record low price of $20.76. There was a -5.98% decline on 12/06/2017 that led the price to move at $46.35. At recent session, the prices were hovering between $45.03 and $46.83. This company shares are 33.46% off its target price of $61.86 and the current market capitalization stands at $8.62B. The recent change has given its price a -13.29% deficit over SMA 50 and -20.2% deficit over its 52-week high. The stock witnessed -11.04% declines, -5.29% declines and 15.18% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CC’s volatility during a week at 5.18% and during a month it has been found around 3.88%.The Chemours Company (CC) Top Holders
Institutional investors currently hold around $7.23 billion or 80.1% in CC stock. Look at its top three institutional owners. Vanguard Group Inc owns $892.43 million in The Chemours Company, which represents roughly 10.35% of the company’s market cap and approximately 12.34% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 15,295,695 shares of the stock are valued at $754.08 million. The third largest holder is Fmr Llc, which currently holds $729.83 million worth of this stock and that ownership represents nearly 8.47% of its market capitalization.
At the end of 09/30/2017 reporting period, 219 institutional holders increased their position in The Chemours Company (NYSE:CC) by some 23,485,269 shares, 216 decreased positions by 14,511,932 and 106 held positions by 108,706,366. That puts total institutional holdings at 146,703,567 shares, according to SEC filings. The stock grabbed 83 new institutional investments totaling 4,063,816 shares while 44 institutional investors sold out their entire positions totaling 3,029,993 shares.The Chemours Company (NYSE:CC) Insider Trades
Multiple company employees have indulged in significant insider trading. The Chemours Company disclosed in a document filed with the US Securities and Exchange Commission (SEC) that President, Titanium Tech Snell E Bryan has sold 11,878 shares of The Chemours Company (CC) in trading session dated Nov. 06, 2017. These shares are worth $632,504 and were traded at $53.25 each. The SEC filing shows that Shelton David C performed a sale of 5,908 shares. The SVP, GC & Corp. Secretary disposed these shares by way of transaction on Oct. 13, 2017. The company’s shares were given away at $56.01 per share worth to an income of some $330,907 on account of Shelton David C.
SVP, GC & Corp. Secretary, Shelton David C, sold 13,397 common shares of The Chemours Company (CC) in the open market. In a transaction dated Oct. 10, 2017, the shares were put up for sale at an average price of $55, raking in a sum of $736,835. After this sale, 41,940 common shares of CC are directly owned by the insider, with total stake valued at $1,943,919.
In the transaction dated Oct. 05, 2017, the great number of shares disposed came courtesy the SVP, GC & Corp. Secretary; Shelton David C disposed a total of 19,000 shares at an average price of $53.68, amounting to approximately $1,019,920. The insider now directly owns 41,940 shares worth $1,943,919.The Chemours Company (CC) Analyst Guide
Several analysts have released their opinion on The Chemours Company (NYSE:CC), with 5 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.33 average brokerage recommendation.